NCT06882980 Comparison of Ciprofol and Propofol Under IoC1 and IoC2 Monitoring for Adenotonsillectomy
| NCT ID | NCT06882980 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Maternal and Child Health Hospital of Hubei Province |
| Condition | Adenotonsillectomy |
| Study Type | INTERVENTIONAL |
| Enrollment | 236 participants |
| Start Date | 2025-02-22 |
| Primary Completion | 2025-10-22 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 236 participants in total. It began in 2025-02-22 with a primary completion date of 2025-10-22.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this clinical trial is to compare the Ciprofol and Propofol Under IoC1 and IoC2 Monitoring for Adenotonsillectomy Participants will be randomly allocated to two groups: Ciprofol group (Group C) and Propofol group (Group P). For those in Group C: they will be given ciprofol during anesthesia induction and maintenance .For those in Group P: they will be pgiven ciprofol during anesthesia induction and maintenanc This study evaluates ciprofol versus propofol under IoC1/IoC2 guidance in pediatric T\&A, providing evidence for ciprofol's efficacy and safety in pediatric anesthesia.
Eligibility Criteria
Inclusion Criteria: * ASA I/II, age 3-11 years, weight 13-50 kg. Endoscopic T\&A or adenoidectomy. Exclusion Criteria: * Recent upper respiratory infection. Difficult airway, organ dysfunction, developmental/psychiatric disorders. Drug allergies.
Contact & Investigator
Na Li, MD
PRINCIPAL INVESTIGATOR
Maternal and Child Health Hospital of Hubei Province
Frequently Asked Questions
Who can join the NCT06882980 clinical trial?
This trial is open to participants of all sexes, aged 3 Years or older, up to 11 Years, studying Adenotonsillectomy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06882980 currently recruiting?
Yes, NCT06882980 is actively recruiting participants. Contact the research team at Email:lina@hbfy.com for enrollment information.
Where is the NCT06882980 trial being conducted?
This trial is being conducted at Wuhan, China.
Who is sponsoring the NCT06882980 clinical trial?
NCT06882980 is sponsored by Maternal and Child Health Hospital of Hubei Province. The principal investigator is Na Li, MD at Maternal and Child Health Hospital of Hubei Province. The trial plans to enroll 236 participants.